Trials / Completed
CompletedNCT06011434
Testing Conversation Aid in Practice
Testing a Conversation Aid on Mammography Screening for Clinicians and Women 75 and Older in Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 155 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- Female
- Age
- 75 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
The goal of this research study is to develop and test a website to help primary care providers (PCPs) discuss the pros and cons of mammography with women aged 75 and older and to help participants make decisions about mammography.
Detailed description
This research study is to conduct a pilot pretest-posttest trial to learn if providing a web-based conversation aid (CA) on mammography screening to 36 primary care providers facilitates shared decision making (SDM) and 8 medical assistants with 190 of their patients (2-3 per PCP) aged 75-89 years and 23 involved family members. Research procedures include screening for eligibility, questionnaires, and clinic visits. Participation in this research study is expected to last about 4 months. It is expected about 90 participants, 23 participant family members, 36 primary care providers, and 8 medical assistants will participant in this research study. The National Institute on Aging is supporting this research study by providing funding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mammography Screening Conversation Aid | Web-based, "Decide Together" conversation aid designed to be used by PCP and participant for shared decision making and to provide information on the benefits and harms of mammography screening as well as educational talking points. |
Timeline
- Start date
- 2024-05-06
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-08-25
- Last updated
- 2026-02-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06011434. Inclusion in this directory is not an endorsement.